Added to YB: 2023-03-31
Pitch date: 2023-03-31
MDGL [bullish]
Madrigal Pharmaceuticals, Inc.
+109.15%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
Market Cap
$12.0B
Pitch Price
$245.56
Price Target
N/A
Dividend
N/A
EV/EBITDA
-37.11
P/E
-38.02
EV/Sales
10.15
Sector
Biotechnology
Category
N/A
Show full summary:
MADRIGAL PHARMACEUTICALS INC MDGL
A summary for this pitch has not been created yet.
Read full article (0 min)